IP Library Granted Patent US 8,765,174
Granted Patent B2
US 8,765,174 · App. 13/327,293 · Granted Jul 1, 2014

Chewable soft capsule

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,765,174
App. No.
13/327,293
Granted
Jul 1, 2014
Kind
B2
Abstract

A matrix formulation for a soft chewable capsule is provided which includes a gel-forming composition, a plasticizer, a polymer modifier, and water. The polymer modifier may be a carboxylic acid or other organic compound that alters the physical and/or chemical properties of the capsule formulation. A chewable soft capsule is also provided, having enhanced organo-leptic and processing properties. An active material may be delivered to a user using this dosage form. A method of forming the chewable soft capsule is also provided.

Claims (26)

1. A method for making a chewable soft capsule comprising:

(i) combining a first gel-forming composition comprising one or more of gelatin, partially hydrolyzed gelatin, hydrolyzed gelatin carbohydrates, carbopolymers, polysaccharides, starch, modified starch, alginates, hydroxylpropylmethyl cellulose, methyl cellulose, or combinations thereof; a plasticizer; and water to form a matrix;

(ii) incubating the matrix for a sufficient time to form a flowable matrix; and

(iii) encapsulating the flowable matrix in a sheath comprising a second gel-forming composition comprising one or more of gelatin, partially hydrolyzed gelatin, hydrolyzed gelatin, carbohydrates, carbopolymers, polysaccharides, starch, modified starch, alginates, hydroxylpropylmethyl cellulose, methyl cellulose, or combinations thereof; a plasticizer; and water to form a chewable soft capsule; and

wherein said method further comprises:

combining a polymer modifier selected from one or more mono-, di-, or poly-carboxylic acids, or combinations thereof in the first gel-forming composition, in the second gel-forming composition, or in both gel-forming compositions.

2. The method of claim 1 , wherein said polymer modifier is selected from the group consisting of lactic acid, fumaric acid, tartaric acid, citric acid, glycolic acid, salts thereof, buffers thereof, and combinations thereof.

3. The method of claim 2 , wherein said polymer modifier is citric acid.

4. The method of claim 1 , wherein the polymer modifier content of the chewable soft capsule comprises about 0.1% to about 10% by weight.

5. The method of claim 1 , wherein the polymer modifier content of the chewable soft capsule comprises about 0.25% to about 5% by weight.

6. The method of claim 1 , wherein the first gel-forming composition comprises gelatin exhibiting a bloom in the range of about 20 to about 250.

7. The method of claim 1 , wherein the first gel-forming composition comprises gelatin exhibiting a bloom in the range of about 40 to about 80.

8. The method of claim 1 , wherein the incubating is for about 4 to about 72 hours.

9. The method of claim 1 , wherein the temperature of the combined matrix is maintained in a range of about 40° C. to about 75° C. during the incubating.

10. The method of claim 1 , further comprising cooling the matrix prior to encapsulating.

11. The method of claim 1 , wherein the water content of the chewable soft capsule comprises about 5% to about 20% by weight.

12. The method of claim 1 , wherein the second gel-forming composition comprises gelatin exhibiting a bloom in the range of about 20 to about 250.

13. The method of claim 1 , wherein the second gel-forming composition comprises gelatin exhibiting a bloom in the range of about 40 to about 80.

14. The method of claim 1 , wherein the first gel-forming composition comprises about 15% to about 80% of the matrix by weight.

15. The method of claim 1 , wherein the second gel-forming composition comprises about 10% to about 70% of the sheath by weight.

16. The method of claim 1 , wherein the plasticizer content of the first gel-forming composition comprises about 10% to about 50% by weight.

17. The method of claim 1 , wherein the plasticizer content of the second gel-forming composition comprises about 1% to about 10% by weight.

18. The method of claim 1 , wherein the plasticizer comprises a polyol.

19. The method of claim 18 , wherein the polyol comprises glycerol, sorbitol, maltitol, xylitol, or combinations thereof.

20. The method of claim 1 , wherein the first gel-forming composition further comprises an active ingredient.

21. The method of claim 20 , wherein, wherein the active ingredient is selected from the group consisting of NTHEs, analgesics, antihistaminics, anti-asthmatics, anti-epileptics, antibiotics, decongestants, anti-allergenics, and food supplements.

Assignments (10)
RELEASE (REEL 032403 / FRAME 0790) Recorded Sep 28, 2017
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BANNER PHARMACAPS INC.
Reel/Frame 044038/0028 →
NOTICE OF SUCCESSION OF AGENCY FOR PATENT SECURITY INTEREST PREVIOUSLY RECORDED AT REEL/FRAME (032403/0790) Recorded Jul 12, 2017
From: UBS AG, STAMFORD BRANCH, AS PRIOR AGENT
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS SUCCESSOR AGENT
Reel/Frame 043173/0005 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 29, 2017
From: BANNER LIFE SCIENCES LLC
To: PATHEON SOFTGELS INC
Reel/Frame 043032/0619 →
RELEASE OF SECURITY INTEREST Recorded Jul 31, 2015
From: UBS AG, STAMFORD BRANCH
To: BANNER LIFE SCIENCES LLC; BANNER PHARMACAPS INC.
Reel/Frame 036224/0623 →
RELEASE OF SECURITY INTEREST Recorded Jul 31, 2015
From: UBS AG, STAMFORD BRANCH
To: BANNER LIFE SCIENCES LLC
Reel/Frame 036239/0188 →
SECURITY INTEREST Recorded Mar 5, 2015
From: BANNER LIFE SCIENCES LLC
To: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
Reel/Frame 035133/0328 →
NUNC PRO TUNC ASSIGNMENT Recorded Nov 19, 2014
From: BANNER PHARMACAPS INC
To: BANNER LIFE SCIENCES LLC
Reel/Frame 034294/0916 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT RIGHTS Recorded Apr 23, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: BANNER PHARMACAPS INC.
Reel/Frame 032745/0454 →
SECURITY INTEREST Recorded Mar 11, 2014
From: BANNER PHARMACAPS INC.
To: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
Reel/Frame 032403/0790 →
SECURITY AGREEMENT Recorded Dec 17, 2012
From: BANNER PHARMACAPS INC.
To: MORGAN STANLEY SENIOR FUNDING INC., AS COLLATERAL AGENT
Reel/Frame 029481/0962 →